Dysfibrinogenemia With the γSer358Cys Variant, Fibrinogen Milano VII, Escapes From the Clauss-CWA Classification
Corresponding Author
Atsuo Suzuki
Department of Medical Technique, Nagoya University Hospital, Nagoya, Japan
Correspondence:
Atsuo Suzuki ([email protected])
Search for more papers by this authorNobuaki Suzuki
Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorShogo Tamura
Department of Clinical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan
Search for more papers by this authorShuichi Okamoto
Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
Search for more papers by this authorTakeshi Kanematsu
Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorTetsuhito Kojima
Aichi Health Promotion Foundation, Nagoya, Japan
Search for more papers by this authorTadashi Matsushita
Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorCorresponding Author
Atsuo Suzuki
Department of Medical Technique, Nagoya University Hospital, Nagoya, Japan
Correspondence:
Atsuo Suzuki ([email protected])
Search for more papers by this authorNobuaki Suzuki
Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorShogo Tamura
Department of Clinical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan
Search for more papers by this authorShuichi Okamoto
Division of Cellular and Genetic Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan
Search for more papers by this authorTakeshi Kanematsu
Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorTetsuhito Kojima
Aichi Health Promotion Foundation, Nagoya, Japan
Search for more papers by this authorTadashi Matsushita
Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan
Search for more papers by this authorFunding: This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant 22K08502 to A.S.).
Open Research
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author.
Supporting Information
| Filename | Description |
|---|---|
| ijlh14451-sup-0001-Figures.docxWord 2007 document , 67.3 KB |
Figure S1. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 A. Suzuki, N. Suzuki, T. Kanematsu, et al., “Clot Waveform Analysis in Clauss Fibrinogen Assay Contributes to Classification of Fibrinogen Disorders,” Thrombosis Research 174 (2019): 98–103, https://doi.org/10.1016/j.thromres.2018.12.018.
- 2 A. Casini, A. Undas, R. Palla, J. Thachil, P. de Moerloose, and Subcommittee on Factor XIII and Fibrinogen, “Diagnosis and Classification of Congenital Fibrinogen Disorders: Communication From the SSC of the ISTH,” Journal of Thrombosis and Haemostasis 16, no. 9 (2018): 1887–1890, https://doi.org/10.1111/jth.14216.
- 3 I. Mackie, A. Casini, M. Pieters, R. Pruthi, C. Reilly-Stitt, and A. Suzuki, “International Council for Standardisation in Haematology Recommendations on Fibrinogen Assays, Thrombin Clotting Time and Related Tests in the Investigation of Bleeding Disorders,” International Journal of Laboratory Hematology 46, no. 1 (2023): 20–32, https://doi.org/10.1111/ijlh.14201.
- 4 A. Suzuki, N. Suzuki, T. Kanematsu, et al., “Development and Validation of a Novel Qualitative Test for Plasma Fibrinogen Utilizing Clot Waveform Analysis,” Scientific Reports 12, no. 1 (2022): 434, https://doi.org/10.1038/s41598-021-04464-5.
- 5 C. Steinmann, C. Bogli, M. Jungo, et al., “A New Substitution, Gamma 358 Ser→ Cys, in Fibrinogen Milano VII Causes Defective Fibrin Polymerization,” Blood 84, no. 6 (1994): 1874–1880, https://doi.org/10.1182/blood.V84.6.1874.1874.
- 6 M. Shima, J. Thachil, S. C. Nair, A. Srivastava, and Scientific Standardization C, “Towards Standardization of Clot Waveform Analysis and Recommendations for Its Clinical Applications,” Journal of Thrombosis and Haemostasis 11, no. 7 (2013): 1417–1420, https://doi.org/10.1111/jth.12287.
- 7 A. Suzuki, N. Suzuki, S. Okamoto, et al., “Prevalence Estimation of Dysfibrinogenemia Using the Clauss-CWA Approach,” International Journal of Laboratory Hematology 47, no. 2 (2025): 297–303, https://doi.org/10.1111/ijlh.14408.
- 8
J. B. Lefkowitz, T. DeBoom, A. Weller, S. Clarke, and D. Lavrinets, “Fibrinogen Longmont: A Dysfibrinogenemia That Causes Prolonged Clot-Based Test Results Only When Using an Optical Detection Method,” American Journal of Hematology 63, no. 3 (2000): 149–155.
10.1002/(SICI)1096-8652(200003)63:3<149::AID-AJH8>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 9
B. Leung, J. Beggs, and J. Mason, “Fibrinogen Longmont: A Clinically Heterogeneous Dysfibrinogenemia With Discrepant Fibrinogen Results Influenced by Clot Detection Method and Reagent,” TH Open 6, no. 1 (2022): 18–20, https://doi.org/10.1055/s-0041-1740644.
10.1055/s-0041-1740644 Google Scholar
- 10 A. Casini, M. Blondon, V. Tintillier, et al., “Mutational Epidemiology of Congenital Fibrinogen Disorders,” Thrombosis and Haemostasis 118, no. 11 (2018): 1867–1874, https://doi.org/10.1055/s-0038-1673685.
- 11 R. Ramanan, J. D. McFadyen, A. C. Perkins, and H. A. Tran, “Congenital Fibrinogen Disorders: Strengthening Genotype–Phenotype Correlations Through Novel Genetic Diagnostic Tools,” British Journal of Haematology 203, no. 3 (2023): 355–368, https://doi.org/10.1111/bjh.19039.
- 12 S. Arai, T. Kamijo, T. Kaido, et al., “Automated Screening Procedure for the Phenotypes of Congenital Fibrinogen Disorders Using Novel Parameters, |min1|c and Ac/|min1|c, Obtained From Clot Waveform Analysis Using the Clauss Method,” Clinica Chimica Acta 521 (2021): 170–176, https://doi.org/10.1016/j.cca.2021.07.012.
